Genovac AG, headquartered in Germany, is a leading player in the biotechnology industry, specialising in the development of innovative antibody discovery and engineering solutions. Founded in 2000, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, offering a range of services that include monoclonal antibody production and custom assay development. With a strong presence in Europe and North America, Genovac AG is renowned for its unique proprietary technologies that streamline the antibody discovery process, significantly reducing time-to-market for therapeutic candidates. The company has achieved notable milestones, including collaborations with major pharmaceutical companies, which underscore its market position as a key contributor to advancements in biopharmaceutical research. Genovac AG continues to drive innovation, making it a pivotal entity in the evolving landscape of biotechnology.
How does Genovac AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Genovac AG's score of 59 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genovac AG, headquartered in Germany, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family under Danaher Corporation, which influences its climate commitments and initiatives. As a current subsidiary of Danaher Corporation, Genovac AG's climate strategies and targets are aligned with those set by its parent company. Danaher has established various sustainability initiatives, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to drive significant reductions in greenhouse gas emissions across their operations. While specific reduction targets for Genovac AG are not detailed, the overarching goals from Danaher Corporation suggest a commitment to improving environmental performance and reducing carbon footprints. This includes efforts to enhance energy efficiency and transition to renewable energy sources, although specific metrics or timelines for Genovac AG are not provided. In summary, while Genovac AG does not have publicly available emissions data or specific reduction targets, it is positioned within a framework of sustainability initiatives led by Danaher Corporation, reflecting a commitment to addressing climate change and reducing carbon emissions in the industry.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 138,341,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 219,166,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genovac AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.